{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001660","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.498770+00:00","generated_at":"2026-05-17T07:00:13.831324+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Artelo Biosciences amends bylaws; eliminates stockholder written consent, adopts Nevada control share provisions","bullets":["Board eliminated stockholders' right to act by written consent, effective immediately.","Bylaws updated to treat Artelo as Nevada 'issuing corporation' under NRS 78.378-78.3793.","Record date for shareholder meetings and dividends capped at 60 days prior to action.","Notice period for special board meetings revised; details in filed amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001660","json":"https://secwatch.observer/filing/0001640334-25-001660.json","markdown":"https://secwatch.observer/filing/0001640334-25-001660.md","text":"https://secwatch.observer/filing/0001640334-25-001660.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001660/0001640334-25-001660-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001660/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:00:13.831324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45a48c2bb9557a89b601436a47c6e575568a2f02","claim":"ARTELO BIOSCIENCES, INC.: Amended bylaws to change special meeting notice period, eliminate stockholder action by written consent, clarify status as issuing corporation under NRS 78.378-78.3793, and set record date limit of 60 days (effective 2025-09-09).","evidence_excerpt":"On September 9, 2025, the board of directors (the “Board”) of Artelo Biosciences, Inc. (the “Company”) amended the Company’s amended and restated bylaws, as provided in a Certificate of Amendment to Bylaws (the “Bylaws Amendment”), as follows: · The required notice period for special meetings of the Board has been updated, as provided in the Bylaws Amendment; · The right of stockholders to take action without a meeting has been eliminated; · The Bylaws have been updated to provide that the Company shall in all respects be considered an “issuing corporation” for purposes of the provisions of NRS 78.378 to 78.3793 inclusive, irrespective of whether the Company, as of any date, (i) has 200 or more stockholders of record, at least 100 of whom have had addresses in Nevada appearing on the stock ledger of the Company at all times during the 90 days immediately preceding such date, and/or (ii) does business in Nevada directly or through an affiliated corporation; and · The Bylaws have been up","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001660/0001640334-25-001660-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-09-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}